News

In a major concern surrounding Europe’s pharma industry, there is an anticipation that it could go on to lose out to elevated competition from emerging markets like China as well as the US when one talks of innovation and...

The pharmaceutical industry is currently facing various challenges, including concerns about pricing due to the Inflation Reduction Act and increased scrutiny from the Federal Trade Commission on merger deals. This has affected the potential for buyouts that were meant...

Thermo Fisher Scientific Inc. has completed its acquisition of MarqMetrix, a privately held developer of Raman-based spectroscopy solutions for in-line measurement. The terms of the deal were not disclosed. Based in Seattle, WA, MarqMetrix provides innovative and fit-for-purpose in-line Process...

Novo Nordisk will invest $2 billion starting in 2023 to expand an existing Active Pharmaceutical Ingredient (API) production facility in Hillerød, Denmark to support its future portfolio in serious chronic diseases. The facility will create additional production capacity and increase...

SK pharmteco, SK Inc.'s contract development manufacturing organization (CDMO) for pharmaceuticals, completed its second facility for cell and gen e therapies (CGT) manufacturing in Europe. With this milestone, SK pharmteco is rapidly expanding its presence in the global market. SK pharmteco...

Women’s health has often been overlooked despite involving 50% of the population. However, there is growing recognition of the differences in health needs and outcomes between men and women. Scientific breakthroughs, new technologies, and policies provide unique opportunities to...

Croda International Plc (Croda) announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. The first partnership is an exclusive license agreement with Amyris, a...